Bayforest Capital’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
Bayforest Capital's MIRM Position: Q3 2026 in Review
Bayforest Capital opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2026: 1,465 shares worth $125K. The stake represents 0.19% of the portfolio and ranks #183 among its holdings.
317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.
- Bayforest Capital held 1,465 shares of Mirum Pharmaceuticals worth $125K as of Q3 2026.
- Mirum Pharmaceuticals was a new Bayforest Capital position in Q3 2026.
- Mirum Pharmaceuticals made up 0.19% of Bayforest Capital's portfolio in Q3 2026, its #183 holding.
- 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.
Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.